nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—Methantheline—HRH2—coronary artery disease	0.0231	1	CrCbGaD
Propantheline—Hypersensitivity—Fenofibrate—coronary artery disease	0.00116	0.00192	CcSEcCtD
Propantheline—Constipation—Olmesartan—coronary artery disease	0.00116	0.00191	CcSEcCtD
Propantheline—Confusional state—Furosemide—coronary artery disease	0.00115	0.0019	CcSEcCtD
Propantheline—Rash—Rosuvastatin—coronary artery disease	0.00115	0.00189	CcSEcCtD
Propantheline—Tachycardia—Perindopril—coronary artery disease	0.00115	0.00189	CcSEcCtD
Propantheline—Dermatitis—Rosuvastatin—coronary artery disease	0.00115	0.00189	CcSEcCtD
Propantheline—Urticaria—Simvastatin—coronary artery disease	0.00115	0.00189	CcSEcCtD
Propantheline—Insomnia—Trandolapril—coronary artery disease	0.00115	0.00189	CcSEcCtD
Propantheline—Hypersensitivity—Clopidogrel—coronary artery disease	0.00114	0.00188	CcSEcCtD
Propantheline—Anaphylactic shock—Furosemide—coronary artery disease	0.00114	0.00188	CcSEcCtD
Propantheline—Insomnia—Enalapril—coronary artery disease	0.00114	0.00188	CcSEcCtD
Propantheline—Headache—Rosuvastatin—coronary artery disease	0.00114	0.00188	CcSEcCtD
Propantheline—Hypersensitivity—Lovastatin—coronary artery disease	0.00114	0.00187	CcSEcCtD
Propantheline—Tension—Ramipril—coronary artery disease	0.00114	0.00187	CcSEcCtD
Propantheline—Asthenia—Fenofibrate—coronary artery disease	0.00113	0.00187	CcSEcCtD
Propantheline—Somnolence—Trandolapril—coronary artery disease	0.00113	0.00185	CcSEcCtD
Propantheline—Insomnia—Telmisartan—coronary artery disease	0.00113	0.00185	CcSEcCtD
Propantheline—Nervousness—Ramipril—coronary artery disease	0.00112	0.00185	CcSEcCtD
Propantheline—Vomiting—Acetylsalicylic acid—coronary artery disease	0.00112	0.00185	CcSEcCtD
Propantheline—Dry mouth—Losartan—coronary artery disease	0.00112	0.00185	CcSEcCtD
Propantheline—Somnolence—Enalapril—coronary artery disease	0.00112	0.00185	CcSEcCtD
Propantheline—Flushing—Lisinopril—coronary artery disease	0.00112	0.00184	CcSEcCtD
Propantheline—Feeling abnormal—Olmesartan—coronary artery disease	0.00112	0.00184	CcSEcCtD
Propantheline—Constipation—Pravastatin—coronary artery disease	0.00112	0.00184	CcSEcCtD
Propantheline—Rash—Acetylsalicylic acid—coronary artery disease	0.00111	0.00184	CcSEcCtD
Propantheline—Hypersensitivity—Ezetimibe—coronary artery disease	0.00111	0.00184	CcSEcCtD
Propantheline—Asthenia—Clopidogrel—coronary artery disease	0.00111	0.00184	CcSEcCtD
Propantheline—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.00111	0.00183	CcSEcCtD
Propantheline—Confusional state—Losartan—coronary artery disease	0.00111	0.00183	CcSEcCtD
Propantheline—Tension—Timolol—coronary artery disease	0.00111	0.00183	CcSEcCtD
Propantheline—Asthenia—Lovastatin—coronary artery disease	0.00111	0.00182	CcSEcCtD
Propantheline—Somnolence—Telmisartan—coronary artery disease	0.00111	0.00182	CcSEcCtD
Propantheline—Anaphylactic shock—Losartan—coronary artery disease	0.0011	0.00182	CcSEcCtD
Propantheline—Nervousness—Timolol—coronary artery disease	0.0011	0.00181	CcSEcCtD
Propantheline—Insomnia—Captopril—coronary artery disease	0.00109	0.0018	CcSEcCtD
Propantheline—Asthenia—Ezetimibe—coronary artery disease	0.00109	0.00179	CcSEcCtD
Propantheline—Constipation—Trandolapril—coronary artery disease	0.00108	0.00178	CcSEcCtD
Propantheline—Urticaria—Valsartan—coronary artery disease	0.00108	0.00178	CcSEcCtD
Propantheline—Nausea—Rosuvastatin—coronary artery disease	0.00108	0.00178	CcSEcCtD
Propantheline—Constipation—Enalapril—coronary artery disease	0.00108	0.00178	CcSEcCtD
Propantheline—Urticaria—Olmesartan—coronary artery disease	0.00108	0.00177	CcSEcCtD
Propantheline—Somnolence—Captopril—coronary artery disease	0.00108	0.00177	CcSEcCtD
Propantheline—Tachycardia—Losartan—coronary artery disease	0.00108	0.00177	CcSEcCtD
Propantheline—Feeling abnormal—Pravastatin—coronary artery disease	0.00107	0.00177	CcSEcCtD
Propantheline—Vision blurred—Timolol—coronary artery disease	0.00107	0.00176	CcSEcCtD
Propantheline—Constipation—Telmisartan—coronary artery disease	0.00106	0.00175	CcSEcCtD
Propantheline—Hypersensitivity—Simvastatin—coronary artery disease	0.00106	0.00175	CcSEcCtD
Propantheline—Insomnia—Perindopril—coronary artery disease	0.00106	0.00175	CcSEcCtD
Propantheline—Asthenia—Eplerenone—coronary artery disease	0.00106	0.00175	CcSEcCtD
Propantheline—Urticaria—Niacin—coronary artery disease	0.00105	0.00173	CcSEcCtD
Propantheline—Nausea—Acetylsalicylic acid—coronary artery disease	0.00105	0.00173	CcSEcCtD
Propantheline—Dizziness—Fenofibrate—coronary artery disease	0.00104	0.00172	CcSEcCtD
Propantheline—Somnolence—Perindopril—coronary artery disease	0.00104	0.00172	CcSEcCtD
Propantheline—Feeling abnormal—Trandolapril—coronary artery disease	0.00104	0.00172	CcSEcCtD
Propantheline—Feeling abnormal—Enalapril—coronary artery disease	0.00104	0.00171	CcSEcCtD
Propantheline—Urticaria—Pravastatin—coronary artery disease	0.00104	0.00171	CcSEcCtD
Propantheline—Asthenia—Simvastatin—coronary artery disease	0.00103	0.00171	CcSEcCtD
Propantheline—Constipation—Captopril—coronary artery disease	0.00103	0.0017	CcSEcCtD
Propantheline—Tension—Lisinopril—coronary artery disease	0.00103	0.0017	CcSEcCtD
Propantheline—Dizziness—Clopidogrel—coronary artery disease	0.00103	0.00169	CcSEcCtD
Propantheline—Feeling abnormal—Telmisartan—coronary artery disease	0.00103	0.00169	CcSEcCtD
Propantheline—Palpitations—Ramipril—coronary artery disease	0.00102	0.00169	CcSEcCtD
Propantheline—Dizziness—Lovastatin—coronary artery disease	0.00102	0.00168	CcSEcCtD
Propantheline—Nervousness—Lisinopril—coronary artery disease	0.00102	0.00168	CcSEcCtD
Propantheline—Somnolence—Furosemide—coronary artery disease	0.00102	0.00167	CcSEcCtD
Propantheline—Urticaria—Trandolapril—coronary artery disease	0.00101	0.00166	CcSEcCtD
Propantheline—Constipation—Perindopril—coronary artery disease	0.001	0.00165	CcSEcCtD
Propantheline—Vomiting—Fenofibrate—coronary artery disease	0.001	0.00165	CcSEcCtD
Propantheline—Hypersensitivity—Valsartan—coronary artery disease	0.001	0.00165	CcSEcCtD
Propantheline—Urticaria—Enalapril—coronary artery disease	0.001	0.00165	CcSEcCtD
Propantheline—Dizziness—Ezetimibe—coronary artery disease	0.001	0.00165	CcSEcCtD
Propantheline—Palpitations—Timolol—coronary artery disease	0.001	0.00165	CcSEcCtD
Propantheline—Feeling abnormal—Captopril—coronary artery disease	0.000997	0.00164	CcSEcCtD
Propantheline—Insomnia—Losartan—coronary artery disease	0.000996	0.00164	CcSEcCtD
Propantheline—Rash—Fenofibrate—coronary artery disease	0.000996	0.00164	CcSEcCtD
Propantheline—Dermatitis—Fenofibrate—coronary artery disease	0.000995	0.00164	CcSEcCtD
Propantheline—Headache—Fenofibrate—coronary artery disease	0.000989	0.00163	CcSEcCtD
Propantheline—Vision blurred—Lisinopril—coronary artery disease	0.000989	0.00163	CcSEcCtD
Propantheline—Urticaria—Telmisartan—coronary artery disease	0.000988	0.00163	CcSEcCtD
Propantheline—Vomiting—Clopidogrel—coronary artery disease	0.000987	0.00163	CcSEcCtD
Propantheline—Vomiting—Lovastatin—coronary artery disease	0.000981	0.00162	CcSEcCtD
Propantheline—Somnolence—Losartan—coronary artery disease	0.000979	0.00161	CcSEcCtD
Propantheline—Dizziness—Eplerenone—coronary artery disease	0.000979	0.00161	CcSEcCtD
Propantheline—Rash—Clopidogrel—coronary artery disease	0.000979	0.00161	CcSEcCtD
Propantheline—Dermatitis—Clopidogrel—coronary artery disease	0.000978	0.00161	CcSEcCtD
Propantheline—Asthenia—Valsartan—coronary artery disease	0.000977	0.00161	CcSEcCtD
Propantheline—Constipation—Furosemide—coronary artery disease	0.000976	0.00161	CcSEcCtD
Propantheline—Hypersensitivity—Niacin—coronary artery disease	0.000976	0.00161	CcSEcCtD
Propantheline—Asthenia—Olmesartan—coronary artery disease	0.000973	0.0016	CcSEcCtD
Propantheline—Headache—Clopidogrel—coronary artery disease	0.000973	0.0016	CcSEcCtD
Propantheline—Rash—Lovastatin—coronary artery disease	0.000972	0.0016	CcSEcCtD
Propantheline—Dermatitis—Lovastatin—coronary artery disease	0.000971	0.0016	CcSEcCtD
Propantheline—Feeling abnormal—Perindopril—coronary artery disease	0.000968	0.00159	CcSEcCtD
Propantheline—Headache—Lovastatin—coronary artery disease	0.000966	0.00159	CcSEcCtD
Propantheline—Dry mouth—Ramipril—coronary artery disease	0.000964	0.00159	CcSEcCtD
Propantheline—Vomiting—Ezetimibe—coronary artery disease	0.000962	0.00158	CcSEcCtD
Propantheline—Hypersensitivity—Pravastatin—coronary artery disease	0.000961	0.00158	CcSEcCtD
Propantheline—Dizziness—Simvastatin—coronary artery disease	0.000954	0.00157	CcSEcCtD
Propantheline—Rash—Ezetimibe—coronary artery disease	0.000954	0.00157	CcSEcCtD
Propantheline—Dermatitis—Ezetimibe—coronary artery disease	0.000953	0.00157	CcSEcCtD
Propantheline—Confusional state—Ramipril—coronary artery disease	0.000953	0.00157	CcSEcCtD
Propantheline—Asthenia—Niacin—coronary artery disease	0.00095	0.00157	CcSEcCtD
Propantheline—Headache—Ezetimibe—coronary artery disease	0.000948	0.00156	CcSEcCtD
Propantheline—Anaphylactic shock—Ramipril—coronary artery disease	0.000945	0.00156	CcSEcCtD
Propantheline—Dry mouth—Timolol—coronary artery disease	0.000942	0.00155	CcSEcCtD
Propantheline—Constipation—Losartan—coronary artery disease	0.000942	0.00155	CcSEcCtD
Propantheline—Vomiting—Eplerenone—coronary artery disease	0.000941	0.00155	CcSEcCtD
Propantheline—Feeling abnormal—Furosemide—coronary artery disease	0.000941	0.00155	CcSEcCtD
Propantheline—Nausea—Fenofibrate—coronary artery disease	0.000938	0.00155	CcSEcCtD
Propantheline—Asthenia—Pravastatin—coronary artery disease	0.000936	0.00154	CcSEcCtD
Propantheline—Rash—Eplerenone—coronary artery disease	0.000933	0.00154	CcSEcCtD
Propantheline—Urticaria—Perindopril—coronary artery disease	0.000933	0.00154	CcSEcCtD
Propantheline—Hypersensitivity—Trandolapril—coronary artery disease	0.000933	0.00154	CcSEcCtD
Propantheline—Dermatitis—Eplerenone—coronary artery disease	0.000933	0.00154	CcSEcCtD
Propantheline—Confusional state—Timolol—coronary artery disease	0.000931	0.00153	CcSEcCtD
Propantheline—Hypersensitivity—Enalapril—coronary artery disease	0.000929	0.00153	CcSEcCtD
Propantheline—Palpitations—Lisinopril—coronary artery disease	0.000928	0.00153	CcSEcCtD
Propantheline—Headache—Eplerenone—coronary artery disease	0.000927	0.00153	CcSEcCtD
Propantheline—Anaphylactic shock—Timolol—coronary artery disease	0.000924	0.00152	CcSEcCtD
Propantheline—Nausea—Clopidogrel—coronary artery disease	0.000922	0.00152	CcSEcCtD
Propantheline—Tachycardia—Ramipril—coronary artery disease	0.000922	0.00152	CcSEcCtD
Propantheline—Vomiting—Simvastatin—coronary artery disease	0.000917	0.00151	CcSEcCtD
Propantheline—Hypersensitivity—Telmisartan—coronary artery disease	0.000917	0.00151	CcSEcCtD
Propantheline—Nausea—Lovastatin—coronary artery disease	0.000916	0.00151	CcSEcCtD
Propantheline—Rash—Simvastatin—coronary artery disease	0.00091	0.0015	CcSEcCtD
Propantheline—Dermatitis—Simvastatin—coronary artery disease	0.000909	0.0015	CcSEcCtD
Propantheline—Asthenia—Trandolapril—coronary artery disease	0.000909	0.0015	CcSEcCtD
Propantheline—Feeling abnormal—Losartan—coronary artery disease	0.000908	0.0015	CcSEcCtD
Propantheline—Urticaria—Furosemide—coronary artery disease	0.000907	0.00149	CcSEcCtD
Propantheline—Asthenia—Enalapril—coronary artery disease	0.000905	0.00149	CcSEcCtD
Propantheline—Headache—Simvastatin—coronary artery disease	0.000904	0.00149	CcSEcCtD
Propantheline—Dizziness—Valsartan—coronary artery disease	0.000901	0.00148	CcSEcCtD
Propantheline—Nausea—Ezetimibe—coronary artery disease	0.000898	0.00148	CcSEcCtD
Propantheline—Dizziness—Olmesartan—coronary artery disease	0.000896	0.00148	CcSEcCtD
Propantheline—Asthenia—Telmisartan—coronary artery disease	0.000893	0.00147	CcSEcCtD
Propantheline—Nausea—Eplerenone—coronary artery disease	0.000879	0.00145	CcSEcCtD
Propantheline—Dizziness—Niacin—coronary artery disease	0.000876	0.00144	CcSEcCtD
Propantheline—Urticaria—Losartan—coronary artery disease	0.000875	0.00144	CcSEcCtD
Propantheline—Dry mouth—Lisinopril—coronary artery disease	0.000874	0.00144	CcSEcCtD
Propantheline—Asthenia—Captopril—coronary artery disease	0.000868	0.00143	CcSEcCtD
Propantheline—Vomiting—Valsartan—coronary artery disease	0.000866	0.00143	CcSEcCtD
Propantheline—Confusional state—Lisinopril—coronary artery disease	0.000864	0.00142	CcSEcCtD
Propantheline—Dizziness—Pravastatin—coronary artery disease	0.000862	0.00142	CcSEcCtD
Propantheline—Vomiting—Olmesartan—coronary artery disease	0.000862	0.00142	CcSEcCtD
Propantheline—Rash—Valsartan—coronary artery disease	0.000859	0.00142	CcSEcCtD
Propantheline—Dermatitis—Valsartan—coronary artery disease	0.000858	0.00141	CcSEcCtD
Propantheline—Nausea—Simvastatin—coronary artery disease	0.000857	0.00141	CcSEcCtD
Propantheline—Anaphylactic shock—Lisinopril—coronary artery disease	0.000857	0.00141	CcSEcCtD
Propantheline—Rash—Olmesartan—coronary artery disease	0.000855	0.00141	CcSEcCtD
Propantheline—Insomnia—Ramipril—coronary artery disease	0.000854	0.00141	CcSEcCtD
Propantheline—Dermatitis—Olmesartan—coronary artery disease	0.000854	0.00141	CcSEcCtD
Propantheline—Headache—Valsartan—coronary artery disease	0.000853	0.00141	CcSEcCtD
Propantheline—Headache—Olmesartan—coronary artery disease	0.000849	0.0014	CcSEcCtD
Propantheline—Asthenia—Perindopril—coronary artery disease	0.000843	0.00139	CcSEcCtD
Propantheline—Vomiting—Niacin—coronary artery disease	0.000842	0.00139	CcSEcCtD
Propantheline—Hypersensitivity—Furosemide—coronary artery disease	0.000841	0.00139	CcSEcCtD
Propantheline—Somnolence—Ramipril—coronary artery disease	0.00084	0.00138	CcSEcCtD
Propantheline—Dizziness—Trandolapril—coronary artery disease	0.000837	0.00138	CcSEcCtD
Propantheline—Tachycardia—Lisinopril—coronary artery disease	0.000836	0.00138	CcSEcCtD
Propantheline—Insomnia—Timolol—coronary artery disease	0.000835	0.00138	CcSEcCtD
Propantheline—Rash—Niacin—coronary artery disease	0.000835	0.00138	CcSEcCtD
Propantheline—Dermatitis—Niacin—coronary artery disease	0.000834	0.00137	CcSEcCtD
Propantheline—Dizziness—Enalapril—coronary artery disease	0.000834	0.00137	CcSEcCtD
Propantheline—Headache—Niacin—coronary artery disease	0.00083	0.00137	CcSEcCtD
Propantheline—Vomiting—Pravastatin—coronary artery disease	0.000829	0.00137	CcSEcCtD
Propantheline—Dizziness—Telmisartan—coronary artery disease	0.000823	0.00136	CcSEcCtD
Propantheline—Rash—Pravastatin—coronary artery disease	0.000822	0.00135	CcSEcCtD
Propantheline—Dermatitis—Pravastatin—coronary artery disease	0.000822	0.00135	CcSEcCtD
Propantheline—Somnolence—Timolol—coronary artery disease	0.000821	0.00135	CcSEcCtD
Propantheline—Asthenia—Furosemide—coronary artery disease	0.000819	0.00135	CcSEcCtD
Propantheline—Headache—Pravastatin—coronary artery disease	0.000817	0.00135	CcSEcCtD
Propantheline—Hypersensitivity—Losartan—coronary artery disease	0.000812	0.00134	CcSEcCtD
Propantheline—Nausea—Valsartan—coronary artery disease	0.000809	0.00133	CcSEcCtD
Propantheline—Constipation—Ramipril—coronary artery disease	0.000808	0.00133	CcSEcCtD
Propantheline—Nausea—Olmesartan—coronary artery disease	0.000805	0.00133	CcSEcCtD
Propantheline—Vomiting—Trandolapril—coronary artery disease	0.000805	0.00133	CcSEcCtD
Propantheline—Vomiting—Enalapril—coronary artery disease	0.000802	0.00132	CcSEcCtD
Propantheline—Dizziness—Captopril—coronary artery disease	0.0008	0.00132	CcSEcCtD
Propantheline—Rash—Trandolapril—coronary artery disease	0.000798	0.00132	CcSEcCtD
Propantheline—Dermatitis—Trandolapril—coronary artery disease	0.000798	0.00131	CcSEcCtD
Propantheline—Rash—Enalapril—coronary artery disease	0.000795	0.00131	CcSEcCtD
Propantheline—Dermatitis—Enalapril—coronary artery disease	0.000795	0.00131	CcSEcCtD
Propantheline—Headache—Trandolapril—coronary artery disease	0.000793	0.00131	CcSEcCtD
Propantheline—Vomiting—Telmisartan—coronary artery disease	0.000791	0.0013	CcSEcCtD
Propantheline—Asthenia—Losartan—coronary artery disease	0.00079	0.0013	CcSEcCtD
Propantheline—Headache—Enalapril—coronary artery disease	0.00079	0.0013	CcSEcCtD
Propantheline—Nausea—Niacin—coronary artery disease	0.000787	0.0013	CcSEcCtD
Propantheline—Rash—Telmisartan—coronary artery disease	0.000784	0.00129	CcSEcCtD
Propantheline—Dermatitis—Telmisartan—coronary artery disease	0.000784	0.00129	CcSEcCtD
Propantheline—Headache—Telmisartan—coronary artery disease	0.000779	0.00128	CcSEcCtD
Propantheline—Feeling abnormal—Ramipril—coronary artery disease	0.000778	0.00128	CcSEcCtD
Propantheline—Dizziness—Perindopril—coronary artery disease	0.000777	0.00128	CcSEcCtD
Propantheline—Insomnia—Lisinopril—coronary artery disease	0.000775	0.00128	CcSEcCtD
Propantheline—Nausea—Pravastatin—coronary artery disease	0.000775	0.00128	CcSEcCtD
Propantheline—Vomiting—Captopril—coronary artery disease	0.000769	0.00127	CcSEcCtD
Propantheline—Rash—Captopril—coronary artery disease	0.000763	0.00126	CcSEcCtD
Propantheline—Dermatitis—Captopril—coronary artery disease	0.000762	0.00126	CcSEcCtD
Propantheline—Somnolence—Lisinopril—coronary artery disease	0.000762	0.00125	CcSEcCtD
Propantheline—Feeling abnormal—Timolol—coronary artery disease	0.000761	0.00125	CcSEcCtD
Propantheline—Headache—Captopril—coronary artery disease	0.000758	0.00125	CcSEcCtD
Propantheline—Dizziness—Furosemide—coronary artery disease	0.000755	0.00124	CcSEcCtD
Propantheline—Nausea—Trandolapril—coronary artery disease	0.000752	0.00124	CcSEcCtD
Propantheline—Urticaria—Ramipril—coronary artery disease	0.00075	0.00124	CcSEcCtD
Propantheline—Nausea—Enalapril—coronary artery disease	0.000749	0.00123	CcSEcCtD
Propantheline—Vomiting—Perindopril—coronary artery disease	0.000747	0.00123	CcSEcCtD
Propantheline—Rash—Perindopril—coronary artery disease	0.000741	0.00122	CcSEcCtD
Propantheline—Dermatitis—Perindopril—coronary artery disease	0.00074	0.00122	CcSEcCtD
Propantheline—Nausea—Telmisartan—coronary artery disease	0.000739	0.00122	CcSEcCtD
Propantheline—Headache—Perindopril—coronary artery disease	0.000736	0.00121	CcSEcCtD
Propantheline—Urticaria—Timolol—coronary artery disease	0.000734	0.00121	CcSEcCtD
Propantheline—Constipation—Lisinopril—coronary artery disease	0.000733	0.00121	CcSEcCtD
Propantheline—Dizziness—Losartan—coronary artery disease	0.000729	0.0012	CcSEcCtD
Propantheline—Vomiting—Furosemide—coronary artery disease	0.000726	0.0012	CcSEcCtD
Propantheline—Rash—Furosemide—coronary artery disease	0.00072	0.00119	CcSEcCtD
Propantheline—Dermatitis—Furosemide—coronary artery disease	0.000719	0.00119	CcSEcCtD
Propantheline—Nausea—Captopril—coronary artery disease	0.000719	0.00118	CcSEcCtD
Propantheline—Headache—Furosemide—coronary artery disease	0.000715	0.00118	CcSEcCtD
Propantheline—Feeling abnormal—Lisinopril—coronary artery disease	0.000706	0.00116	CcSEcCtD
Propantheline—Vomiting—Losartan—coronary artery disease	0.0007	0.00115	CcSEcCtD
Propantheline—Nausea—Perindopril—coronary artery disease	0.000698	0.00115	CcSEcCtD
Propantheline—Hypersensitivity—Ramipril—coronary artery disease	0.000696	0.00115	CcSEcCtD
Propantheline—Rash—Losartan—coronary artery disease	0.000695	0.00114	CcSEcCtD
Propantheline—Dermatitis—Losartan—coronary artery disease	0.000694	0.00114	CcSEcCtD
Propantheline—Headache—Losartan—coronary artery disease	0.00069	0.00114	CcSEcCtD
Propantheline—Urticaria—Lisinopril—coronary artery disease	0.000681	0.00112	CcSEcCtD
Propantheline—Hypersensitivity—Timolol—coronary artery disease	0.00068	0.00112	CcSEcCtD
Propantheline—Nausea—Furosemide—coronary artery disease	0.000678	0.00112	CcSEcCtD
Propantheline—Asthenia—Ramipril—coronary artery disease	0.000678	0.00112	CcSEcCtD
Propantheline—Asthenia—Timolol—coronary artery disease	0.000663	0.00109	CcSEcCtD
Propantheline—Nausea—Losartan—coronary artery disease	0.000654	0.00108	CcSEcCtD
Propantheline—Hypersensitivity—Lisinopril—coronary artery disease	0.000631	0.00104	CcSEcCtD
Propantheline—Dizziness—Ramipril—coronary artery disease	0.000625	0.00103	CcSEcCtD
Propantheline—Asthenia—Lisinopril—coronary artery disease	0.000615	0.00101	CcSEcCtD
Propantheline—Dizziness—Timolol—coronary artery disease	0.000611	0.00101	CcSEcCtD
Propantheline—Vomiting—Ramipril—coronary artery disease	0.000601	0.00099	CcSEcCtD
Propantheline—Rash—Ramipril—coronary artery disease	0.000596	0.000981	CcSEcCtD
Propantheline—Dermatitis—Ramipril—coronary artery disease	0.000595	0.00098	CcSEcCtD
Propantheline—Headache—Ramipril—coronary artery disease	0.000592	0.000975	CcSEcCtD
Propantheline—Vomiting—Timolol—coronary artery disease	0.000587	0.000967	CcSEcCtD
Propantheline—Rash—Timolol—coronary artery disease	0.000582	0.000959	CcSEcCtD
Propantheline—Dermatitis—Timolol—coronary artery disease	0.000582	0.000958	CcSEcCtD
Propantheline—Headache—Timolol—coronary artery disease	0.000579	0.000953	CcSEcCtD
Propantheline—Dizziness—Lisinopril—coronary artery disease	0.000567	0.000933	CcSEcCtD
Propantheline—Nausea—Ramipril—coronary artery disease	0.000561	0.000924	CcSEcCtD
Propantheline—Nausea—Timolol—coronary artery disease	0.000549	0.000904	CcSEcCtD
Propantheline—Vomiting—Lisinopril—coronary artery disease	0.000545	0.000897	CcSEcCtD
Propantheline—Rash—Lisinopril—coronary artery disease	0.00054	0.00089	CcSEcCtD
Propantheline—Dermatitis—Lisinopril—coronary artery disease	0.00054	0.000889	CcSEcCtD
Propantheline—Headache—Lisinopril—coronary artery disease	0.000537	0.000884	CcSEcCtD
Propantheline—Nausea—Lisinopril—coronary artery disease	0.000509	0.000838	CcSEcCtD
Propantheline—CHRM3—Signaling Pathways—JUNB—coronary artery disease	4.93e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PLCB1—coronary artery disease	4.93e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PLCB1—coronary artery disease	4.91e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPARGC1A—coronary artery disease	4.91e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—HMOX1—coronary artery disease	4.89e-05	0.000132	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JUNB—coronary artery disease	4.88e-05	0.000132	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PLCB1—coronary artery disease	4.87e-05	0.000132	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HTR7—coronary artery disease	4.83e-05	0.00013	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CAT—coronary artery disease	4.82e-05	0.00013	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HTR7—coronary artery disease	4.81e-05	0.00013	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HTR7—coronary artery disease	4.77e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOB—coronary artery disease	4.68e-05	0.000127	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ITGAV—coronary artery disease	4.6e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KNG1—coronary artery disease	4.59e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ITGAV—coronary artery disease	4.59e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KNG1—coronary artery disease	4.57e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—POMC—coronary artery disease	4.57e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CREB1—coronary artery disease	4.57e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AGTR1—coronary artery disease	4.56e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—POMC—coronary artery disease	4.56e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CREB1—coronary artery disease	4.56e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GSTM1—coronary artery disease	4.55e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AGTR1—coronary artery disease	4.54e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ITGAV—coronary artery disease	4.54e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KNG1—coronary artery disease	4.53e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—POMC—coronary artery disease	4.51e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CREB1—coronary artery disease	4.51e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AGTR1—coronary artery disease	4.5e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CCL2—coronary artery disease	4.47e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—LPL—coronary artery disease	4.47e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL6R—coronary artery disease	4.46e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CCL2—coronary artery disease	4.46e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CXCL10—coronary artery disease	4.45e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL6R—coronary artery disease	4.44e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PLG—coronary artery disease	4.44e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CXCL10—coronary artery disease	4.44e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PLG—coronary artery disease	4.43e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CCL2—coronary artery disease	4.41e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL6R—coronary artery disease	4.4e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CXCL10—coronary artery disease	4.4e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PLG—coronary artery disease	4.39e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GPX1—coronary artery disease	4.36e-05	0.000118	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ADRB2—coronary artery disease	4.32e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ADRB2—coronary artery disease	4.31e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PRKCE—coronary artery disease	4.27e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ADRB2—coronary artery disease	4.27e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—JAK2—coronary artery disease	4.27e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SOCS1—coronary artery disease	4.26e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PRKCE—coronary artery disease	4.26e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—JAK2—coronary artery disease	4.25e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—S100B—coronary artery disease	4.25e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CD36—coronary artery disease	4.25e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SOCS1—coronary artery disease	4.25e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—S100B—coronary artery disease	4.24e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PRKCE—coronary artery disease	4.22e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—JAK2—coronary artery disease	4.21e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SOCS3—coronary artery disease	4.21e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SOCS1—coronary artery disease	4.2e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPP2CA—coronary artery disease	4.19e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—S100B—coronary artery disease	4.19e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SOCS3—coronary artery disease	4.19e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KITLG—coronary artery disease	4.16e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TGFBR2—coronary artery disease	4.16e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SOCS3—coronary artery disease	4.15e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KITLG—coronary artery disease	4.14e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TGFBR2—coronary artery disease	4.14e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TGFBR2—coronary artery disease	4.1e-05	0.000111	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KITLG—coronary artery disease	4.1e-05	0.000111	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—STAT5A—coronary artery disease	4.06e-05	0.00011	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MMP3—coronary artery disease	4.06e-05	0.00011	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MMP3—coronary artery disease	4.05e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—STAT5A—coronary artery disease	4.05e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—MTHFR—coronary artery disease	4.02e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STAT5A—coronary artery disease	4.01e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP3—coronary artery disease	4.01e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOB—coronary artery disease	3.93e-05	0.000106	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOB—coronary artery disease	3.91e-05	0.000106	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	3.89e-05	0.000105	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—CXCL8—coronary artery disease	3.88e-05	0.000105	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOB—coronary artery disease	3.88e-05	0.000105	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	3.87e-05	0.000105	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EDN1—coronary artery disease	3.86e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—JAK2—coronary artery disease	3.86e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EDN1—coronary artery disease	3.85e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	3.84e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCL5—coronary artery disease	3.83e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	3.82e-05	0.000103	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AGT—coronary artery disease	3.82e-05	0.000103	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCL5—coronary artery disease	3.82e-05	0.000103	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EDN1—coronary artery disease	3.82e-05	0.000103	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCL5—coronary artery disease	3.79e-05	0.000102	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGF1—coronary artery disease	3.78e-05	0.000102	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CSF2—coronary artery disease	3.78e-05	0.000102	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGF1—coronary artery disease	3.77e-05	0.000102	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CSF2—coronary artery disease	3.77e-05	0.000102	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—LPL—coronary artery disease	3.75e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOE—coronary artery disease	3.75e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—LPL—coronary artery disease	3.74e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CSF2—coronary artery disease	3.73e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGF1—coronary artery disease	3.73e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	3.72e-05	0.0001	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	3.72e-05	0.0001	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	3.7e-05	0.0001	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	3.7e-05	0.0001	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOA1—coronary artery disease	3.7e-05	0.0001	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—LPL—coronary artery disease	3.7e-05	0.0001	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	3.67e-05	9.92e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	3.67e-05	9.92e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	3.62e-05	9.79e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	3.61e-05	9.76e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	3.57e-05	9.66e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	3.54e-05	9.56e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	3.52e-05	9.53e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	3.52e-05	9.51e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	3.51e-05	9.48e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	3.49e-05	9.44e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	3.47e-05	9.39e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	3.45e-05	9.34e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	3.44e-05	9.31e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	3.41e-05	9.22e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	3.38e-05	9.14e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—C3—coronary artery disease	3.38e-05	9.13e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	3.37e-05	9.11e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—C3—coronary artery disease	3.37e-05	9.1e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	3.34e-05	9.02e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—C3—coronary artery disease	3.33e-05	9.01e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPARG—coronary artery disease	3.26e-05	8.82e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	3.22e-05	8.7e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—POMC—coronary artery disease	3.22e-05	8.7e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	3.21e-05	8.68e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AGT—coronary artery disease	3.21e-05	8.67e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AGT—coronary artery disease	3.2e-05	8.64e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	3.18e-05	8.59e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AGT—coronary artery disease	3.17e-05	8.56e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—LEP—coronary artery disease	3.14e-05	8.5e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOE—coronary artery disease	3.14e-05	8.5e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOE—coronary artery disease	3.13e-05	8.47e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—LEP—coronary artery disease	3.13e-05	8.47e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOA1—coronary artery disease	3.11e-05	8.4e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOE—coronary artery disease	3.1e-05	8.39e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—LEP—coronary artery disease	3.1e-05	8.39e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOA1—coronary artery disease	3.1e-05	8.37e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KDR—coronary artery disease	3.08e-05	8.32e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KDR—coronary artery disease	3.07e-05	8.3e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOA1—coronary artery disease	3.07e-05	8.29e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	3.06e-05	8.27e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	3.05e-05	8.24e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KDR—coronary artery disease	3.04e-05	8.22e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	3.02e-05	8.16e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ESR1—coronary artery disease	3e-05	8.11e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ESR1—coronary artery disease	2.99e-05	8.09e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FN1—coronary artery disease	2.96e-05	8.01e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—F2—coronary artery disease	2.96e-05	8.01e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ESR1—coronary artery disease	2.96e-05	8.01e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—F2—coronary artery disease	2.95e-05	7.99e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FN1—coronary artery disease	2.95e-05	7.99e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	2.95e-05	7.98e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	2.94e-05	7.96e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ALB—coronary artery disease	2.93e-05	7.93e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	2.93e-05	7.92e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—F2—coronary artery disease	2.93e-05	7.91e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FN1—coronary artery disease	2.93e-05	7.91e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	2.92e-05	7.89e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	2.91e-05	7.88e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	2.89e-05	7.82e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KIT—coronary artery disease	2.84e-05	7.67e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KIT—coronary artery disease	2.83e-05	7.64e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—NOS3—coronary artery disease	2.81e-05	7.59e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KIT—coronary artery disease	2.8e-05	7.57e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	2.72e-05	7.36e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	2.71e-05	7.33e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—POMC—coronary artery disease	2.7e-05	7.3e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CREB1—coronary artery disease	2.7e-05	7.3e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—POMC—coronary artery disease	2.69e-05	7.28e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CREB1—coronary artery disease	2.69e-05	7.28e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	2.69e-05	7.26e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—POMC—coronary artery disease	2.67e-05	7.21e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CREB1—coronary artery disease	2.67e-05	7.21e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCL2—coronary artery disease	2.64e-05	7.14e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6R—coronary artery disease	2.63e-05	7.12e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCL2—coronary artery disease	2.63e-05	7.12e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6R—coronary artery disease	2.63e-05	7.1e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCL2—coronary artery disease	2.61e-05	7.05e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6R—coronary artery disease	2.6e-05	7.03e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF1—coronary artery disease	2.6e-05	7.02e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF1—coronary artery disease	2.59e-05	7e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	2.58e-05	6.99e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	2.58e-05	6.97e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTGS2—coronary artery disease	2.57e-05	6.94e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF1—coronary artery disease	2.56e-05	6.93e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	2.55e-05	6.9e-05	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.47e-05	6.68e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	2.47e-05	6.67e-05	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	2.46e-05	6.66e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	2.46e-05	6.65e-05	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	2.44e-05	6.59e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	2.43e-05	6.58e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGF2—coronary artery disease	2.39e-05	6.45e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGF2—coronary artery disease	2.38e-05	6.43e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGF2—coronary artery disease	2.36e-05	6.37e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOS3—coronary artery disease	2.35e-05	6.37e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOS3—coronary artery disease	2.35e-05	6.35e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOS3—coronary artery disease	2.32e-05	6.28e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—JAK2—coronary artery disease	2.29e-05	6.19e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—JAK2—coronary artery disease	2.28e-05	6.17e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JAK2—coronary artery disease	2.26e-05	6.11e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	2.24e-05	6.06e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	2.24e-05	6.04e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	2.21e-05	5.99e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	2.09e-05	5.65e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	2.08e-05	5.63e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	2.06e-05	5.57e-05	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	2.02e-05	5.45e-05	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	2.01e-05	5.44e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CASP3—coronary artery disease	2e-05	5.4e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CASP3—coronary artery disease	1.99e-05	5.39e-05	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	1.99e-05	5.38e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL6—coronary artery disease	1.99e-05	5.37e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL6—coronary artery disease	1.98e-05	5.35e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CASP3—coronary artery disease	1.97e-05	5.33e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL6—coronary artery disease	1.96e-05	5.3e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCND1—coronary artery disease	1.95e-05	5.26e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCND1—coronary artery disease	1.94e-05	5.24e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCND1—coronary artery disease	1.92e-05	5.19e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MMP9—coronary artery disease	1.89e-05	5.11e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MMP9—coronary artery disease	1.88e-05	5.09e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP9—coronary artery disease	1.86e-05	5.04e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	1.83e-05	4.95e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	1.83e-05	4.94e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	1.81e-05	4.89e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	1.7e-05	4.59e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	1.69e-05	4.57e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	1.67e-05	4.53e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CA—coronary artery disease	1.58e-05	4.27e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	1.56e-05	4.21e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	1.55e-05	4.2e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	1.54e-05	4.16e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	1.53e-05	4.13e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	1.52e-05	4.11e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	1.51e-05	4.07e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.33e-05	3.58e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	1.32e-05	3.57e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	1.31e-05	3.54e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AKT1—coronary artery disease	1.29e-05	3.49e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6—coronary artery disease	1.17e-05	3.17e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6—coronary artery disease	1.17e-05	3.16e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6—coronary artery disease	1.16e-05	3.13e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT1—coronary artery disease	1.08e-05	2.93e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT1—coronary artery disease	1.08e-05	2.92e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT1—coronary artery disease	1.07e-05	2.89e-05	CbGpPWpGaD
